BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sipponen P, Vauhkonen M, Helske T, Kääriäinen I, Härkönen M. Low circulating levels of gastrin-17 in patients with Barrett's esophagus. World J Gastroenterol 2005; 11(38): 5988-5992 [PMID: 16273611 DOI: 10.3748/wjg.v11.i38.5988]
URL: https://www.wjgnet.com/1007-9327/full/v11/i38/5988.htm
Number Citing Articles
1
Tan Han Loong, Ngiu Chai Soon, Nik Ritza Kosai Nik Mahmud, Jeevinesh Naidu, Rafiz Abdul Rani, Nazefah Abdul Hamid, Marjanu Hikmah Elias, Isa Mohamed Rose, Azmi Tamil, Norfilza M. Mokhtar, Raja Affendi Raja Ali. Serum pepsinogen and gastrin-17 as potential biomarkers for pre-malignant lesions in the gastric corpusBiomedical Reports 2017; 7(5): 460 doi: 10.3892/br.2017.985
2
K. MONKEMULLER, H. NEUMANN, M. NOCON, M. VIETH, J. LABENZ, S. N. WILLICH, M. STOLTE, M. HOCKER, D. JASPERSEN, T. LIND, P. MALFERTHEINER. Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro‐oesophageal reflux disease: a matched case–control studyAlimentary Pharmacology & Therapeutics 2008; 28(4): 491 doi: 10.1111/j.1365-2036.2008.03769.x
3
Congye Wu, Yehong Liu, Feiyue Shi, Fei Chen, Youcai Zhao, Huanyu Zhao. The relationship of serum gastrin-17 and oral mucositis in head and neck carcinoma patients receiving radiotherapyDiscover Oncology 2022; 13(1) doi: 10.1007/s12672-022-00570-6
4
Georgijs Moisejevs, Ilva Daugule, Sergejs Isajevs, Dace Rudzīte, Dainius Janciauskas, Ivars Tolmanis, Marcis Leja. Non-Invasive Diagnosis of Gastroesophageal Reflux Disease Using Gastrin- and Pepsinogen-Based TestsProceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 2018; 72(3): 172 doi: 10.2478/prolas-2018-0028
5
Ryousuke Kikuchi, Yasuhiko Abe, Katsunori Iijima, Tomoyuki Koike, Nobuyuki Ara, Kaname Uno, Kiyotaka Asanuma, Naoki Asano, Akira Imatani, Tooru Shimosegawa. Low Serum Levels of Pepsinogen and Gastrin 17 Are Predictive of Extensive Gastric Atrophy with High-Risk of Early Gastric CancerThe Tohoku Journal of Experimental Medicine 2011; 223(1): 35 doi: 10.1620/tjem.223.35
6
Kari J. Syrjänen, Penti Sipponen, Matti Härkönen, Ants Peetsalu, Semi Korpela. Accuracy of the GastroPanel test in the detection of atrophic gastritisEuropean Journal of Gastroenterology & Hepatology 2015; 27(1): 102 doi: 10.1097/MEG.0000000000000215
7
David C Whiteman, Mark Appleyard, Farzan F Bahin, Yuri V Bobryshev, Michael J Bourke, Ian Brown, Adrian Chung, Andrew Clouston, Emma Dickins, Jon Emery, Guy D Eslick, Louisa G Gordon, Florian Grimpen, Geoff Hebbard, Laura Holliday, Luke F Hourigan, Bradley J Kendall, Eric YT Lee, Angelique Levert‐Mignon, Reginald V Lord, Sarah J Lord, Derek Maule, Alan Moss, Ian Norton, Ian Olver, Darren Pavey, Spiro Raftopoulos, Shan Rajendra, Mark Schoeman, Rajvinder Singh, Freddy Sitas, B Mark Smithers, Andrew C Taylor, Melissa L Thomas, Iain Thomson, Henry To, Jutta von Dincklage, Christine Vuletich, David I Watson, Ian F Yusoff. Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinomaJournal of Gastroenterology and Hepatology 2015; 30(5): 804 doi: 10.1111/jgh.12913
8
Dipti Chourasia, Asha Misra, Shweta Tripathi, Narendra Krishnani, Uday C. Ghoshal. Patients with Helicobacter pylori infection have less severe gastroesophageal reflux disease: a study using endoscopy, 24-hour gastric and esophageal pH metryIndian Journal of Gastroenterology 2011; 30(1): 12 doi: 10.1007/s12664-010-0078-0
9
Vira Boichuk. THE ROLE OF PEPSINOGENES AND SOME INTESTINAL HORMONES IN PATHOGENESIS OF GASTROESOPHAGEAL REFLUX DISEASEEUREKA: Health Sciences 2018; 1: 3 doi: 10.21303/2504-5679.2018.00538
10
Lars Agréus, Ernst J Kuipers, Limas Kupcinskas, Peter Malfertheiner, Francesco Di Mario, Marcis Leja, Varocha Mahachai, Niv Yaron, Martijn van Oijen, Guillermo Perez Perez, Massimo Rugge, Jukka Ronkainen, Mikko Salaspuro, Pentti Sipponen, Kentaro Sugano, Joseph Sung. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkersScandinavian Journal of Gastroenterology 2012; 47(2): 136 doi: 10.3109/00365521.2011.645501
11
Yasuhiko Abe, Katsunori Iijima, Tomoyuki Koike, Kiyotaka Asanuma, Akira Imatani, Shuichi Ohara, Tooru Shimosegawa. Barrett's esophagus is characterized by the absence of Helicobacter pylori infection and high levels of serum pepsinogen I concentration in JapanJournal of Gastroenterology and Hepatology 2009; 24(1): 129 doi: 10.1111/j.1440-1746.2008.05691.x
12
Katsunori Iijima, Yasuhiko Abe, Ryosuke Kikuchi, Tomoyuki Koike, Shuichi Ohara, Pentti Sipponen, Tooru Shimosegawa. Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomachWorld Journal of Gastroenterology 2009; 15(7): 853-859 doi: 10.3748/wjg.15.853
13
Jaanus Suumann, Toomas Sillakivi, Živile Riispere, Kari Syrjänen, Pentti Sipponen, Ülle Kirsimägi, Ants Peetsalu. Serological biomarker testing helps avoiding unnecessary endoscopies in obese patients before bariatric surgeryBMC Obesity 2018; 5(1) doi: 10.1186/s40608-018-0185-5
14
Pentti Sipponen, David Y. Graham. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: Application of plasma biomarkersScandinavian Journal of Gastroenterology 2007; 42(1): 2 doi: 10.1080/00365520600863720
15
Francesco Di Mario, Lorella Franzoni, Marilisa Franceschi, Kryssia Isabel Rodriguez-Castro, Michele Russo, Pellegrino Crafa. Low levels of G17 and Barrett esophagus: a clinical relationshipClinical Chemistry and Laboratory Medicine (CCLM) 2022; 60(7): e165 doi: 10.1515/cclm-2022-0362
16
Suleyman Demiryas, Anıl Orhan. Biomarkers in Medicine2022; : 407 doi: 10.2174/9789815040463122010016
17
Daniel F. Carr, Seyoum Ayehunie, Andrea Davies, Carrie A. Duckworth, Stephanie French, Neil Hall, Syed Hussain, Howard R. Mellor, Alan Norris, B. Kevin Park, Alexander Penrose, D. Mark Pritchard, Chris S. Probert, Shashi Ramaiah, Claire Sadler, Michael Schmitt, Alison Shaw, James E. Sidaway, Robert G. Vries, Matthew Wagoner, Munir Pirmohamed. Towards better models and mechanistic biomarkers for drug-induced gastrointestinal injuryPharmacology & Therapeutics 2017; 172: 181 doi: 10.1016/j.pharmthera.2017.01.002